Caffeine intake by patients with autosomal dominant polycystic kidney disease

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 9, 2012, Pages 834-840

  Vendramini, L C ^a   Nishiura, J L ^a   Baxmann, A C ^a   Heilberg, I P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ADPKD; Caffeine; Cyclic AMP; Nutrition; Polycystic kidneys; Renal volume

Indexed keywords

CAFFEINE; CYCLIC AMP;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BEVERAGE; BODY MASS; CACAO; CARBONATED BEVERAGE; CHRONIC KIDNEY DISEASE; COFFEE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MAJOR CLINICAL STUDY; MALE; NUTRITION; TEA;

EID: 84865385008     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500120     Document Type: Article

References (27)

1. Torres VE. Treatment strategies and clinical trial design in ADPKD. Adv Chronic Kidney Dis 2010; 17: 190-204.
2. Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 838-844.
3. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, et al. Volume progression in polycystic kidney disease. N Engl J Med 2006; 354: 2122-2130.
4. Torres VE. Role of vasopressin antagonists. Clin J Am Soc Nephrol 2008; 3: 1212-1218.
5. Nagao S, Nishii K, Katsuyama M, Kurahashi H, Marunouchi T, Takahashi H, et al. Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol 2006; 17: 2220-2227.
6. Barash I, Ponda MP, Goldfarb DS, Skolnik EY. A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2010; 5: 693-697.
7. Heckman MA, Weil J, Gonzalez de ME. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010; 75: R77-R87.
8. Belibi FA, Wallace DP, Yamaguchi T, Christensen M, Reif G, Grantham JJ. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002; 13: 2723-2729.
9. Tanner GA, Tanner JA. Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease. Am J Kidney Dis 2001; 38: 1089-1095.
10. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2009; 20: 205-212.
11. Camargo MCR, Toledo MC. HPLC determination of caffeine in tea, chocolate products and carbonated beverages. J Sci Food Agric 1999; 79: 1861-1864.
12. Camargo MC, Toledo MC, Farah HG. Caffeine daily intake from dietary sources in Brazil. Food Addit Contam 1999; 16: 79-87.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
14. Frassetto LA, Lanham-New SA, Macdonald HM, Remer T, Sebastian A, Tucker KL, et al. Standardizing terminology for estimating the diet-dependent net acid load to the metabolic system. J Nutr 2007; 137: 1491-1492.
15. Schrier RW, McFann KK, Johnson AM. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 2003; 63: 678-685.
16. Bartels H, Bohmer M, Heierli C. [Serum creatinine determination without protein precipitation]. Clin Chim Acta 1972; 37: 193-197.
17. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
18. Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 2004; 66: 964-973.
19. Moshfegh AJ, Rhodes DG, Baer DJ, Murayi T, Clemens JC, Rumpler WV, et al. The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr 2008; 88: 324-332.
20. Barone JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol 1996; 34: 119-129.
21. Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 2005; 105: 110-113.
22. Mangoo-Karim R, Uchic ME, Grant M, Shumate WA, Calvet JP, Park CH, et al. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J 1989; 3: 2629-2632.
23. O'Neill WC, Robbin ML, Bae KT, Grantham JJ, Chapman AB, Guay-Woodford LM, et al. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). Am J Kidney Dis 2005; 46: 1058-1064.
24. Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2007; 2: 112-120.
25. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 2003; 64: 1035-1045.
26. Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 2006; 1: 148-157.
27. Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis 2002; 39: 1127-1134.